Remove accelerator Remove board Remove digital therapeutics Remove investing
article thumbnail

Biofourmis hits unicorn status after $300m Series D funding

AsiaTechDaily

Register Biofourmis , a Sigapore-founded digital therapeutics firm , announced that it has surpassed unicorn status with a $300 million Series D investment led by leading global growth equity firm General Atlantic. With this investment, Biofourmis plans to scale up its virtual care offerings, according to the announcement.